A new study found that over time, the majority of weight loss from GLP-1 medication was from fat loss, and not muscle loss
[12] [16] They are active over a wide variety of substrates with considerable overlap
Semaglutide is contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), history of pancreatitis, pregnancy or breastfeeding, and severe gastrointestinal disorders such as gastroparesis
Each article in this collection delves into a different aspect of gene therapy's role within the larger narrative of Regenerative Medicine
Patients who are actively trying to conceive or planning pregnancy within the next few months should discuss whether initiating semaglutide is appropriate, given the FDA recommendation to discontinue the medication at least 2 months before planned conception
The team has been prompt with answering my questions